The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Sands Capital Alternatives, LLC

Reporting owner CIK 0001846444 · 10% owner

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Sands Capital Alternatives, LLCSands Capital Alternative…SANDS FRANK M.SANDS FRANK M.Sands Capital Life Sciences Pulse Fund II, L.P.Sands Capital Life Scienc…Sands Capital Alternatives, LLC · November 21, 2025 · Purchase · Common StockSANDS FRANK M. · November 21, 2025 · Purchase · Common StockSands Capital Life Sciences Pulse Fund II, L.P. · November 21, 2025 · Purchase · Common StockNov 21, 2025Nov 21, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

1 dated transactions · 3 of 3 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Nov 21, 2025Inhibikase Therapeutics, Inc.Common StockSands Capital Alternatives, LLC · SANDS FRANK M. · Sands Capital Life Sciences Pulse Fund II, L.P.Purchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Inhibikase Therapeutics, Inc.IKT · company listings
SANDS FRANK M.10% owner
Sands Capital Life Sciences Pulse Fund II, L.P.10% owner
Joint filing · amounts unallocated		PurchaseCommon StockNon-derivative security · Code P2,068,9651.45Value: 2,999,999.25Currency not specifiedView ↗